期刊文献+

癌灶内注射腺病毒介导的血管内皮生长因子启动子-胸苷激酶基因治疗大鼠肝癌 被引量:3

Therapeutic efficacy of adenovirus-mediated gene transfer of thymidine kinase coded with vascular endothelial growth factor promoter on murine experimental hepatocellular carcinoma
原文传递
导出
摘要 目的研究腺病毒介导的血管内皮生长因子启动子调控的单纯疱疹病毒胸苷激酶基因(AdVEGF tk)对大鼠肝癌的治疗作用。方法以二乙基亚硝胺 (DEN)诱导Wistar大鼠产生肝癌 ,将成癌鼠随机分组 ,在同鼠肝内的多发性癌灶中选取 2个孤立的癌灶分别作为参照癌和处理癌 ,记录癌灶直径。参照癌不作处理。处理癌分别用不同的重组腺病毒癌内注射 ,并从次日起连续 10d每天腹腔内给予丙氧鸟苷 (GCV)或生理盐水 1次。停止注射后第 10天剖腹测量处理癌和参照癌大小 ,比较各组间癌灶体积增长率。结果用低浓度DEN处理 12 0d ,所有被探查的大鼠均有典型的肝癌形成。与同鼠中参照癌相比 ,AdVEGF tk/生理盐水处理的癌灶体积增长率平均值差异无显著意义 (P>0 0 5 ) ,而AdCMV tk/GCV和AdVEGF tk/GCV处理的癌灶体积增长率平均值显著降低 (P <0 0 1) ,与AdVEGF tk/生理盐水组处理癌和参照癌的体积增长率平均值之间的差异也有显著意义 (P<0 0 1)。AdVEGF tk/GCV处理癌与AdCMV tk/GCV处理癌体积增长率之间差异无显著意义 (P>0 0 5 )。结论癌灶内注射AdVEGF tk对大鼠肝癌生长具有明显抑制作用。 Objective To investigate the therapeutic efficacy of adenovirus-mediated transfer of thymidine kinase gene controlled by vascular endothelial growth factor promoter against of induced hepatocellular carcinoma in a rat model. MethodsMultiple hepatic neoplastic nodules in Wistar rats were chemically induced by diethylnitrosamine. Two relatively isolated neoplastic nodules of similar size were chosen in each rat to serve as control and to receive intratumor injection of recombinant adenovirus (AdVEGF-tk or AdCMV-tk), and the beginning on the second day ganciclovir (GCV) was given intraperitoneally for consecutive 10 days. Tumor size and tumor growth rates were compared between the two groups. Results There was no difference in the mean growth values between control tumors and AdVEGF-tk/saline-treated tumors( P > 0.05),and between AdCMV-tk/GCV- and AdVEGF-tk/GCV-treated tumors( P >0.05). The mean growth values in AdCMV-tk/GCV- and AdVEGF-tk/GCV-treated tumors were significantly lower than those in untreated tumors and AdVEGF-tk/saline-untreated tumors( P <0.01). Conclusion Intratumor injection of AdVEGF-tk followed by GCV administration impedes the growth of the hepatocellular carcinoma in a rat model.
出处 《中华普通外科杂志》 CSCD 北大核心 2003年第12期744-746,共3页 Chinese Journal of General Surgery
基金 教育部留学回国人员启动基金 (99QD3 )
关键词 癌灶内注射 腺病毒介导 血管内皮生长因子 启动子 胸苷激酶 基因治疗 肝癌 Carcinoma,hepatocellular Endothelial growth factors Herpes simplex virus-thymidine kinase Adenoviral vector
  • 相关文献

参考文献9

  • 1王孟龙,殷正丰,吴宗娣,王率,吴孟超.腺病毒介导的VEGF启动子-胸苷激酶表达系统对肝癌细胞的选择性杀伤作用[J].第二军医大学学报,2002,23(1):12-14. 被引量:4
  • 2王孟龙,殷正丰,吴宗娣,王率,钱海华,康晓燕,吴孟超.缺氧对血管内皮生长因子启动子-胸苷激酶系统杀伤肝癌细胞系的增强作用[J].中华肿瘤杂志,2002,24(5):455-457. 被引量:3
  • 3Rajewsky MF;Dauber W;Frankenberg H.Liver carcinogenesis by diethylnitrosamine in the rat[J],1966.
  • 4GerolamiR;Cardoso J;Lewin M.Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes[J],2000.
  • 5Teicher BA.Hypoxia and drug resistance[J],1994.
  • 6Dachs GU;Patterson AV;Firth JD.Targeting gene expression to hypoxic tumor cells[J],1997.
  • 7Mazure NM;Chen EY;Yeh P.Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression,1996(15).
  • 8Rabes HM;Szymkowiak R.Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis,1979.
  • 9Forsythe JA;Jiang BH;Iyer NV.Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1[J],1996.

二级参考文献19

  • 1Grunstein J, Roberts WG, Mathieu-Costello O, et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res,1999,59:1592-1598.
  • 2Miura H, Miyazaki T, Kuroda M, et al. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol,1997,27:854-861.
  • 3Mazure NM, Chen EY, Yeh P, et al. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res, 1996,56: 3436-3440.
  • 4He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA,1998,95:2509-2514.
  • 5Mansour SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature,1988,336:348-352.
  • 6Shibata T, Akiyama N, Noda M, et al. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int J Radiat Oncol Biol Phys,1998,42:913-916.
  • 7Kaneko S, Hallenbeck P, Kotani T, et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res, 1995,55:5283-5287.
  • 8Greco O, Dachs GU. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. J Cell Physiol,2001,187:22-36.
  • 9Dachs GU, Dougherty GJ, Stratford IJ, et al. Targeting gene therapy to cancer: a review. Oncol Res,1997,9:313-325.
  • 10Brekken RA, Huang X, King SW, et al. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res,1998,58:1952-1959.

共引文献5

同被引文献7

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部